Search research articles
Contact Us
Filters
Showing results (71-80 of 182) with videos related to
Page
of 19
Sort By:
Cancer Research
|
December 20, 2007
Proapoptotic BH3-only BCL-2 family protein BIM connects death signaling from epidermal growth factor receptor inhibition to the mitochondrion
Jing Deng, Takeshi Shimamura, Samanthi Perera, et al.
Oncotarget
|
April 20, 2016
Complementary dynamic BH3 profiles predict co-operativity between the multi-kinase inhibitor TG02 and the BH3 mimetic ABT-199 in acute myeloid leukaemia cells
Monica Pallis, Francis Burrows, Jeremy Ryan, et al.
Blood
|
July 22, 2015
Direct and immune-mediated cytotoxicity of interleukin-21 contributes to antitumor effects in mantle cell lymphoma
Shruti Bhatt, Julie Matthews, Salma Parvin, et al.
Cancer Discovery
|
November 18, 2017
Found in Translation: How Preclinical Research Is Guiding the Clinical Development of the BCL2-Selective Inhibitor Venetoclax
Joel D Leverson, Deepak Sampath, Andrew J Souers, et al.
Cell Death & Disease
|
April 13, 2023
Quantifying requirements for mitochondrial apoptosis in CAR T killing of cancer cells
Alexandra L Pourzia, Michael L Olson, Stefanie R Bailey, et al.
Cell Death and Differentiation
|
December 20, 2024
Senolysis by ABT-263 is associated with inherent apoptotic dependence of cancer cells derived from the non-senescent state
Fleur Jochems, Chrysiida Baltira, Julie A MacDonald, et al.
Nature Cell Biology
|
March 14, 2018
Diminished apoptotic priming and ATM signalling confer a survival advantage onto aged haematopoietic stem cells in response to DNA damage
Paula Gutierrez-Martinez, Leah Hogdal, Manavi Nagai, et al.
Blood
|
September 8, 2012
Decreased mitochondrial apoptotic priming underlies stroma-mediated treatment resistance in chronic lymphocytic leukemia
Matthew S Davids, Jing Deng, Adrian Wiestner, et al.
Cell Stem Cell
|
August 20, 2013
High mitochondrial priming sensitizes hESCs to DNA-damage-induced apoptosis
Julia C Liu, Xiao Guan, Jeremy A Ryan, et al.
Molecular Cell
|
October 1, 2013
BID preferentially activates BAK while BIM preferentially activates BAX, affecting chemotherapy response
Kristopher A Sarosiek, Xiaoke Chi, John A Bachman, et al.
Page
of 19
Search research articles
Search
Showing results (71-80 of 182) with videos related to
Sort By:
Page
of 19
Cancer Research
|
December 20, 2007
Proapoptotic BH3-only BCL-2 family protein BIM connects death signaling from epidermal growth factor receptor inhibition to the mitochondrion
Jing Deng, Takeshi Shimamura, Samanthi Perera, et al.
Oncotarget
|
April 20, 2016
Complementary dynamic BH3 profiles predict co-operativity between the multi-kinase inhibitor TG02 and the BH3 mimetic ABT-199 in acute myeloid leukaemia cells
Monica Pallis, Francis Burrows, Jeremy Ryan, et al.
Blood
|
July 22, 2015
Direct and immune-mediated cytotoxicity of interleukin-21 contributes to antitumor effects in mantle cell lymphoma
Shruti Bhatt, Julie Matthews, Salma Parvin, et al.
Cancer Discovery
|
November 18, 2017
Found in Translation: How Preclinical Research Is Guiding the Clinical Development of the BCL2-Selective Inhibitor Venetoclax
Joel D Leverson, Deepak Sampath, Andrew J Souers, et al.
Cell Death & Disease
|
April 13, 2023
Quantifying requirements for mitochondrial apoptosis in CAR T killing of cancer cells
Alexandra L Pourzia, Michael L Olson, Stefanie R Bailey, et al.
Cell Death and Differentiation
|
December 20, 2024
Senolysis by ABT-263 is associated with inherent apoptotic dependence of cancer cells derived from the non-senescent state
Fleur Jochems, Chrysiida Baltira, Julie A MacDonald, et al.
Nature Cell Biology
|
March 14, 2018
Diminished apoptotic priming and ATM signalling confer a survival advantage onto aged haematopoietic stem cells in response to DNA damage
Paula Gutierrez-Martinez, Leah Hogdal, Manavi Nagai, et al.
Blood
|
September 8, 2012
Decreased mitochondrial apoptotic priming underlies stroma-mediated treatment resistance in chronic lymphocytic leukemia
Matthew S Davids, Jing Deng, Adrian Wiestner, et al.
Cell Stem Cell
|
August 20, 2013
High mitochondrial priming sensitizes hESCs to DNA-damage-induced apoptosis
Julia C Liu, Xiao Guan, Jeremy A Ryan, et al.
Molecular Cell
|
October 1, 2013
BID preferentially activates BAK while BIM preferentially activates BAX, affecting chemotherapy response
Kristopher A Sarosiek, Xiaoke Chi, John A Bachman, et al.
Page
of 19